Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04741606Aexternal-prioritypatent/EP1631298B8/en
Application filed by Umberto CornellifiledCriticalUmberto Cornelli
Publication of CY1107092T1publicationCriticalpatent/CY1107092T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Polysaccharides And Polysaccharide Derivatives
(AREA)
Abstract
Η παρούσα εφεύρεση εξετάζει τη χρήση κλασμάτων γλυκοζαμινογλυκάνης με μέσο μοριακό βάρος 2400 (V200) D για την παρασκευή φαρμακευτικών συνθέσεων κατάλληλων για τη θεραπεία συναισθηματικών δυσλειτουργιών και, ειδικότερα, για διαταραχές κατάθλιψης, διαταραχές άγχους, αγχώδη νεύρωση, ανησυχία, σύγχυση.The present invention contemplates the use of glycosaminoglycan fractions with an average molecular weight of 2400 (V200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions and, in particular, for depression disorders, anxiety disorders, anxiety, anxiety.
CY20071101592T2003-05-212007-12-14
USE OF GLYCOSAMINOGLYCANS FOR THE TREATMENT OF EMOTIONAL DISEASES
CY1107092T1
(en)
use of a human interleukin-2 mutein (hil-2 mutein) or a fragment thereof, pharmaceutical composition for the treatment and / or prophylaxis of an autoimmune disease, use of human interleukin-2 mutein (hil-2 mutein) 2) or a section thereof, for the formation of regulatory t cells (treg) in an organism, method for treatment and / or prophylaxis of an autoimmune disease in an organism, method for formation of regulatory t cells (treg) in an organism organism, method for formation of regulatory t cells (treg) in vitro.
Derivatives of 1,2,3,4-tetrahydropyrrolo- [1,2-a] -pyrazine-6-carboxamides and 2,3,4,5-tetrahydropyrrolo- (1,2-a) -diazepine-7-carbamide , THEIR PREPARATION AND THEIR APPLICATION TO THERAPEUTIC EDUCATION